Pediatric Endocrinology Diabetes and Metabolism
en ENGLISH
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Standardy etyczne i procedury Suplementy Zasady publikacji prac Opłaty publikacyjne
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
Wyszukiwanie
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

without publication fees

Zintegrowane z publons

integrated with publons
Poleć ten artykuł:
Wyślij znajomemu
Udostępnij:
Artykuł oryginalny

Zespół policystycznych jajników u matki a ryzyko zaburzeń neurorozwojowych u noworodków urodzonych przedwcześnie

Noorjan Abdullah Muhammed
1
,
Mufeed Akram Taha
2
,
Esraa Abdulkareem Mohammed
3
,
Wassan Nori
4

  1. Department of Paediatrics, College of Medicine, University of Kirkuk, Iraq
  2. Department of Medicine, College of Medicine, University of Kirkuk, Iraq
  3. Department of Obstetrics and Gynecology, College of Medicine, University of Kirkuk, Iraq
  4. Department of Obstetrics and Gynaecology, Mustansiriyah University, Baghdad, Iraq
Pediatr Endocrinol Diabetes Metab 2026; 32 (2)
DOI: https://doi.org/10.5114/pedm.2026.161348
Data publikacji online: 2026/05/16
Plik artykułu:
- 0426_Maternal polycystic.pdf  [0.81 MB]
Pobierz cytowanie
 
Metryki PlumX:
 
1. Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol 2025; 21: 230–244. doi: 10.1038/s41574-024-01057-w.
2. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol 2023; 189: G43–G64. doi: 10.1093/ejendo/lvad096.
3. Pirotta S, Joham A, Grieger JA, et al. Obesity and the risk of infertility, gestational diabetes, and type 2 diabetes in polycystic ovary syndrome. Semin Reprod Med 2020; 38: 342–351. doi: 10.1055/s-0041-1726866.
4. Lim SS, Kakoly NS, Tan JWJ, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev 2019; 20: 339–352. doi: 10.1111/obr.12762.
5. Popoola M, Ohaeri B, Adubi IO, Babarimisa O. Preterm birth, prevention, prediction, care. Eur J Med Health Sci 2023; 5: 6–10. doi: 10.24018/ejmed.2023.5.1.1441.
6. Daskalakis G, Psarris A, Koutras A, et al. Maternal infection and preterm birth: from molecular basis to clinical implications. Children (Basel) 2023; 10: 907. doi: 10.3390/children10050907.
7. Farland LV, Stern JE, Liu CL, et al. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts. Hum Reprod 2022; 37: 2690–2699. doi: 10.1093/humrep/deac210.
8. Hincapie MA, Badeghiesh A, Baghlaf H, Dahan MH. Association between pre-gestational diabetes in women with polycystic ovary syndrome and adverse obstetric outcomes. Eur J Obstet Gynecol Reprod Biol 2025; 304: 109–114. doi: 10.1016/j.ejogrb.2024.11.021.
9. Khomami MB, Shorakae S, Hashemiet S, et al. Systematic review and meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Nat Commun 2024; 15: 5591. doi: 10.1038/s41467-024-49749-1.
10. Sekar S, Fernando S, Budithi S. Association between polycystic ovarian syndrome and incompetent uterine cervix: a systematic review and meta-analysis. J Gynecol Obstet Hum Reprod 2024; 53: 102763. doi: 10.1016/j.jogoh.2024.102763.
11. Amisi CA. Markers of insulin resistance in polycystic ovary syndrome women: an update. World J Diabetes 2022; 13: 129. doi: 10.4239/wjd.v13.i3.129.
12. Abiramalatha T, Bandyopadhyay T, Ramaswamy VV, et al. Risk factors for periventricular leukomalacia in preterm infants: a systematic review, meta-analysis, and GRADE-based assessment of certainty of evidence. Pediatr Neurol; 124: 51–71. doi: 10.1016/j.pediatrneurol.2021.08.003
13. Taha MA, Taha SA, Mohammed EA. Pentraxin-3 level assessment among ischemic stroke patients with polycystic ovarian syndrome. Diyala J Med 2025; 29: 31–41. doi: 10.26505/djm.v29i1.1384.
14. Rasouli MA, Katz J, Dumesic DA. Interface between reproductive and metabolic dysfunction in polycystic ovary syndrome. Curr Opin Obstet Gynecol 2025; 37: 167–174.
15. Rahman M, Rahman FT, Mallik MU, Saha J. Metabolic dysfunctions in polycystic ovary syndrome. J Med 2024; 25: 68–77. doi: 10.3329/jom.v25i1.70703.
16. Kim HJ, Kim EH, Ko E, et al. The impact of polycystic ovary syndrome on gestational diabetes mellitus, disease knowledge, and health behaviors. Healthcare (Basel) 2025; 13: 717. doi: 10.3390/healthcare13070717.
17. Sultana S, Horiuchi S, Homer CS, et al. The prevalence of long-term neurodevelopmental outcomes in preterm-born children in low- and middle-income countries: a systematic review and meta-analysis. J Glob Health 2025; 15: 04106. doi: 10.7189/jogh.15.04106.
18. Swarray-Deen A, Sepenu P, Mensah TE, et al. Preterm birth in low-middle income countries. Best Pract Res Clin Obstet Gynaecol 2024; 95: 102518. doi: 10.1016/j.bpobgyn.2024.102518.
19. Cao Q, Wang R, Zhou R, et al. The early development of offspring born to women with polycystic ovary syndrome: insights from a prospective birth cohort study in Southwestern China. Psychoneuroendocrinology 2024; 163: 106984. doi: 10.1016/j.psyneuen.2024.106984.
20. Ban M, Sun Y, Chen X, et al. Association between maternal polycystic ovarian syndrome undergoing assisted reproductive technology and pregnancy complications and neonatal outcomes: a systematic review and meta-analysis. J Ovarian Res 2024; 17: 6. doi: 10.1186/s13048-023-01331-x.
21. Chung EH, Chou J, Brown KA. Neurodevelopmental outcomes of preterm infants: a recent literature review. Transl Pediatr 2020; 9: S3. doi: 10.21037/tp.2019.09.10.
22. Neven AC, Mousa A, Boyle JA, Teede HJ. Endocrine and metabolic interactions in healthy pregnancies and hyperinsulinemic pregnancies affected by polycystic ovary syndrome, diabetes and obesity. Front Endocrinol (Lausanne) 2023; 13: 993619. doi: 10.3389/fendo.2022.993619.
23. Velez LM, Seldin M, Motta AB. Inflammation and reproductive function in women with polycystic ovary syndrome. Biol Reprod 2021; 104: 1205–1217. doi: 10.1093/biolre/ioab050.
24. Sigal WM, Alzahrani O, Guadalupe GM, et al. Natural history and neurodevelopmental outcomes in perinatal stress induced hyperinsulinism. Front Pediatr 2022; 10: 999274. doi: 10.3389/fped.2022.999274.
25. Périsset A, Natalucci G, Adams M, et al. Impact of low-grade intraventricular hemorrhage on neurodevelopmental outcome in very preterm infants at two years of age. Early Hum Dev 2023; 177: 105721. doi: 10.1016/j.earlhumdev.2023.105721.
26. Shah V, Musrap N, Maharaj K, et al. Grading of intraventricular hemorrhage and neurodevelopment in preterm <29 weeks’ GA in Canada. Children (Basel) 2022; 9: 1948. doi: 10.3390/children9121948.
27. Richer EJ, Riedesel EL, Linam LE. Review of neonatal and infant cranial US. Radiographics 2021; 41: E206–E207. doi: 10.1148/rg.2021210089.
28. Pisani F, Spagnoli C, Falsaperla R, et al. Seizures in the neonate: a review of etiologies and outcomes. Seizure 2021; 85: 48–56. doi: 10.1016/j.seizure.2020.12.023.
29. Fornes R, Simin J, Nguyen MH, et al. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study. Reprod Biol Endocrinol 2022; 20: 30. doi: 10.1186/s12958-022-00905-6.
30. Boldis BV, Grünberger I, Cederström A, et al. Early life factors and polycystic ovary syndrome in a Swedish birth cohort. Int J Environ Res Public Health 2023; 20: 7083. doi: 10.3390/ijerph20227083.
31. Ehrhardt H, Aubert AM, Ådén U, et al. Apgar score and neuro-developmental outcomes at age 5 years in infants born extremely preterm. JAMA Netw Open 2023; 6: e2332413. doi: 10.1001/jamanetworkopen.2023.32413.
32. Shah PS, Norman M, Rusconi F, et al. Five-minute Apgar score and outcomes in neonates of 24–28 weeks’ gestation. Arch Dis Child Fetal Neonatal Ed 2022; 107: 437–446. doi: 10.1136/archdischild-2021-322230.
33. Lin XS, Peng XY, Yang MM, et al. The single pregnancy predicting model of 1 minute Apgar score less than 7 after preterm birth: a retrospective study. PLoS One 2022; 17: e0279385. doi: 10.1371/journal.pone.0279385.
34. Dubey P, Thakur B, Rodriguez S, et al. A systematic review and meta-analysis of the association between maternal polycystic ovary syndrome and neuropsychiatric disorders in children. Transl Psychiatry 2021; 11: 569. doi: 10.1038/s41398-021-01699-8.
35. Kahn LG, Hipwell AE, Charifson M, et al. Maternal polycystic ovarian syndrome and offspring psychopathology and neurodevelopment. Hum Reprod 2025; 40: 1257–1265. doi: 10.1093/humrep/deaf079.


Termedia
O Wydawnictwie Oferty Newsletter Kontakt Praca
Polityka prywatności Polityka reklamowa Napisz do nas Nota prawna Regulamin
Na skróty
Aktualności Czasopisma Książki eBooki Konferencje i webinary Podcasty Mednauka
Serwisy
KONGRES TOP MEDICAL TRENDS Menedżer Zdrowia Lekarz POZ Choroby rzadkie Dermatologia Diabetologia Onkologia Neurologia Reumatologia Gastroenterologia Pulmonologia Ginekologia Kurier Medyczny Zalecenia i rekomendacje e-Praktyka Leczenia Ran Warto wiedzieć Biblioteka podcastów
e-Akademia
e-Akademia Zaburzeń Mikrobioty e-Akademia POChP e-Akademia Chorób Naczyń
© 2026 Termedia Sp. z o.o.
Developed by Termedia.